Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 49.66 USD -0.18% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Inari Medical Inc?
Write Note

Inari Medical Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inari Medical Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Inari Medical Inc
NASDAQ:NARI
Other Long-Term Assets
$2.6m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Long-Term Assets
$2.6B
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
18%
Boston Scientific Corp
NYSE:BSX
Other Long-Term Assets
$4.5B
CAGR 3-Years
-1%
CAGR 5-Years
19%
CAGR 10-Years
28%
Stryker Corp
NYSE:SYK
Other Long-Term Assets
$3.9B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
18%
Abbott Laboratories
NYSE:ABT
Other Long-Term Assets
$7.7B
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Long-Term Assets
$1.6B
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
28%
No Stocks Found

Inari Medical Inc
Glance View

Market Cap
2.9B USD
Industry
Health Care

Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 800 full-time employees. The company went IPO on 2020-05-22. The firm operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.

NARI Intrinsic Value
33.36 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Inari Medical Inc's Other Long-Term Assets?
Other Long-Term Assets
2.6m USD

Based on the financial report for Dec 31, 2023, Inari Medical Inc's Other Long-Term Assets amounts to 2.6m USD.

What is Inari Medical Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
43%

Over the last year, the Other Long-Term Assets growth was 336%. The average annual Other Long-Term Assets growth rates for Inari Medical Inc have been 43% over the past three years .

Back to Top